Merlin Q2 2026: $58.4M Net Loss, Material Weaknesses, and $130M Warrant Liability
MRLN sits 24% above its 52-week low of $3.27.
Summary
Merlin's Q2 2026 10-Q shows a $58.4M net loss, material weaknesses in internal controls, and a $130.1M warrant liability. Cash of $183.6M funds operations for at least 12 months.
Key Events · Earnings and Guidance · MRLN
-
Q2 Net Loss of $58.4M
Net loss widened to $58.4 million from $16.3 million a year ago, driven by a $26.1 million non-cash loss on warrant liability remeasurement and higher operating expenses.
-
Material Weaknesses Disclosed
Management identified material weaknesses in internal control over financial reporting related to non-routine/complex transactions, segregation of duties, and IT general controls.
-
Warrant Liability Surges to $130.1M
Warrant liabilities increased from $76.8 million at year-end to $130.1 million, primarily due to the May 2026 PIPE triggering a down round feature and issuance of additional liability-classified warrants.
-
Down Round Feature Triggers $60.8M Deemed Dividend
The May 2026 PIPE reduced the Series A Preferred Stock conversion price from $12.00 to $6.67, resulting in a $60.8 million deemed dividend to common stockholders.
Analysis · MRLN · Technology
Merlin's Q2 2026 10-Q reveals a $58.4 million net loss, driven by a $26.1 million non-cash loss on warrant liability remeasurement and a $60.8 million deemed dividend from a down round feature triggered by the May 2026 PIPE. The company also discloses material weaknesses in internal controls over financial reporting, including issues with complex transactions, segregation of duties, and IT general controls. While cash of $183.6 million provides runway, the combination of significant losses, control deficiencies, and a complex capital structure with liability-classified warrants creates meaningful risk for investors.
At the time of this filing, MRLN was trading at $4.05 on NASDAQ in the Technology sector, with a market capitalization of approximately $426.6M. The 52-week trading range was $3.27 to $17.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.